Search details
1.
Modeling the novel SERD elacestrant in cultured fulvestrant-refractory HR-positive breast circulating tumor cells.
Breast Cancer Res Treat
; 201(1): 43-56, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37318638
2.
Abagovomab as maintenance therapy in patients with epithelial ovarian cancer: a phase III trial of the AGO OVAR, COGI, GINECO, and GEICO--the MIMOSA study.
J Clin Oncol
; 31(12): 1554-61, 2013 Apr 20.
Article
in English
| MEDLINE | ID: mdl-23478059
Results
1 -
2
de 2
1
Next >
>>